Life science asset database

We regularly hear about new licensing agreements between pharmaceutical and biotech companies. These usually involve assets – such as therapeutics, diagnostics, medical devices or technologies – which are to be developed or marketed together. A big challenge however is to find the right partner for the right asset. The Biotechgate database features almost 90,000 life … Continue reading Life science asset database

Read more

Launch of the Life Science Directory for Medicen Paris

Media Release Launch of the Life Science Directory for Medicen Paris Zurich / Paris, Oct 2020 – Venture Valuation owned Biotechgate announces the partnership with Medicen Paris Region to create a directory of Life Sciences companies. The online directory makes it easier to find partners in one of the key clusters in Europe. Venture Valuation/Biotechgate … Continue reading Launch of the Life Science Directory for Medicen Paris

Read more

Canadian Life Science Market Trend Analysis 2020

Together with our partners – Montreal Invivo, BioAlberta and BIOTECanada – we are happy to present an extended annual report on the Canadian life science market. Besides the usual statistics about companies, products and investments, the new format of the report includes data on clinical trials acquired from the new section of Biotechgate database.

Read more

Denmark Life Science Market Trend Analysis 2020

The number of biotech companies in Denmark relative to the population is one of the highest in the world with Copenhagen being a very important European cluster. Last year Danish biotech was boosted with several large financing rounds with the volume as high as dozens of millions of dollars each. See the details in the … Continue reading Denmark Life Science Market Trend Analysis 2020

Read more

Swiss Life Science Market Trend Analysis 2020

Our annual Swiss market trend analysis compiled with Biotechgate data shows that the life science industry in Switzerland is thriving. The amount of money raised in venture financing rounds in 2019 was nearly twice as large as in 2018. Also, more new biotech companies were launched last year than two years ago.

Read more

The Launch of the Rhine-Main-Neckar Directory

Zurich 03 March 2020 Last month Biotechgate/Venture Valuation entered a partnership with BioRN, the science and industry cluster of the Rhine-Main-Neckar region, with the goal to develop and run a publicly accessible directory of companies located in the region. The Directory has recently been launched and is accessible for free on BioRN’s website. While it … Continue reading The Launch of the Rhine-Main-Neckar Directory

Read more

How we use Big Data for curation of the Clinical Trial Database

The clinical trials database that we launched in March this year, has already grown from the initial 460,000+ records to over 500,000. It has been possible thanks to the integration with more than 13 registries around the world – a result of a Big Data project called DISCOVER in collaboration with the Swiss Institute for … Continue reading How we use Big Data for curation of the Clinical Trial Database

Read more

Partnering and match-making system with data from Biotechgate

Partnering conferences are an essential part of the business development activities in the life science industry. Our premium match-making system HelloPartnering lets conference participants plan and schedule their meetings in advance. What sets HelloPartnering apart is that data about assets and companies is populated from Biotechgate, meaning: No more “empty” company profiles in a conference … Continue reading Partnering and match-making system with data from Biotechgate

Read more

Site Selection Report for Life Sciences Companies in Europe 2018

The new Site Selection Report for Life Sciences Companies in Europe, compiled by KPMG in association with Venture Valuation, explores the when, where and how of successful European expansion. The publication looks beyond site selection to include key work streams involved in successfully commercializing pharmaceutical products in Europe. In the 2018 edition, we identify five … Continue reading Site Selection Report for Life Sciences Companies in Europe 2018

Read more

Launch of a Directory of Life Sciences and Health Technologies companies with an exclusive database in Québec

Zurich / Montréal, November 26, 2018 As part of the ongoing commitment of Montréal InVivo to promote the economic development and growth of the life sciences and health technologies (LSHT) sector in Québec, Biotechgate, a company owned by Venture Valuation, and Montréal InVivo, the LSHT industrial cluster of the Montreal metropolitan area, announce a partnership … Continue reading Launch of a Directory of Life Sciences and Health Technologies companies with an exclusive database in Québec

Read more